Top

LATEST PUBLICATIONS



Amgen bets almost $4B on a biotech and its inflammation drugs

August 4, 2022

Category: Biotech, Industry

Amgen plans to acquire a fellow Californian biotechnology company, ChemoCentryx, for $3.7 billion in a deal meant to deepen its pool of medicines targeting inflammation and the kidneys. The companies expect their deal, announced Thursday, to close sometime between October […]


NewAmsterdam Pharma and Frazier LifeSciences announce merger agreement

July 26, 2022

Via: PMLiVE

Upon closing of the transaction, a newly formed holding company, NewAmsterdam Pharma Company NV, will be led by Michael Davidson, chief executive officer of the company. The Dutch biotech will receive approximately $235m from a private placement led by Frazier […]


Parents Become Drug Developers to Save Their Children’s Lives

July 21, 2022

Category: Industry, Pharma

Maggie Carmichael wasn’t developing like other kids. As a toddler, she wasn’t walking and had a limited vocabulary for her age. She was diagnosed with PMM2-CDG, potentially fatal gene mutations that cause abnormal enzyme activity — and affect fewer than […]


Clinical Trials, Research and Development

Concert to seek approval for hair loss drug after second study success

August 1, 2022

Via: Biopharma Dive

Concert Pharmaceuticals, a small biotechnology company based in Lexington, Massachusetts, plans to seek Food and Drug Administration approval for its experimental hair loss drug after reporting success in the second of two late-stage clinical trials. As in the first study, […]


Cell and Gene Therapy, Industry, News

Sarepta says early filing for DMD gene therapy is back on

August 1, 2022

Via: Pharmaphorum

The US biotech – which already has three antisense drugs for DMD on the market – had said earlier it was planning to delay the application into 2023, so the new announcement marks an acceleration of its plans. Sarepta reported […]


Industry, Vaccines

Pfizer takes COVID jab with ‘enhanced’ spike protein into phase 2

July 27, 2022

Via: Pharmaphorum

The vaccine, codenamed BNT162b5, codes for “enhanced” prefusion spike proteins from the original wild-type strain of the virus and the Omicron variant that are designed to increase “the magnitude and breadth of the immune response.” The phase 2 trial will […]


Industry, Vaccines

Fauci addresses need for pan-coronavirus and intranasal vaccines to combat COVID-19 variants

July 27, 2022

Via: PMLiVE

The National Institute of Allergy and Infectious Diseases (NIAID) director specifically detailed the call for pan-coronavirus candidates and mucosal options that can be given to patients intranasally, all the while reinforcing that “innovative approaches are clearly needed to induce broad […]